Medicare Enrolled
Dr. David Podwall, M.D.
Optician · Lake Success, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Podwall from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Podwall?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Podwall
Dr. David Podwall is an optician specialist in Lake Success, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Podwall performed 3,232 Medicare services across 2,369 unique beneficiaries.
Between the years covered by Open Payments, Dr. Podwall received a total of $21,668 from 77 pharmaceutical and/or device companies across 758 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Podwall is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 24% volume in NY
$21,668 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,232
Medicare services
Top 24% in NY for optician
2,369
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~162 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
583 | $108 | $147 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
518 | $72 | $94 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
356 | $1 | $7 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
222 | $72 | $91 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
160 | $146 | $193 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
126 | $115 | $144 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
126 | $33 | $41 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
125 | $154 | $206 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
115 | $118 | $149 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
94 | $97 | $126 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
93 | $39 | $77 |
| Vestibular function test using rotating chair This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability. |
93 | $121 | $151 |
| Use of electrodes during balance testing Application of electrodes to monitor physiological responses during a balance assessment. |
93 | $10 | $13 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
92 | $53 | $70 |
| Vestibular function test with thermal irrigation A test that assesses balance by irrigating both ears with warm and cool fluids to evaluate inner ear function. |
91 | $36 | $46 |
| Lidocaine HCl injection for IV infusion, 10 mg Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion. |
86 | $0 | $5 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
85 | $34 | $42 |
| New patient office visit, complex (60-74 min) | 75 | $190 | $254 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
56 | $75 | $93 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
31 | $196 | $245 |
| Emergency department visit, high complexity An emergency department visit involving a high level of medical decision making. |
12 | $163 | $203 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.7% high complexity
18.5% medium
78.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$21,668
Total received (2018-2024)
Avg $3,095/year across 7 years
Top 8% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
77
Companies
758
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,513 (62.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,095 (37.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$59 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$11,220
2023
$2,671
2022
$2,392
2021
$2,752
2020
$475
2019
$1,236
2018
$922
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Eisai Inc.
$8,095
ABBVIE INC.
$470
PFIZER INC.
$336
Amgen Inc.
$236
Lundbeck LLC
$218
Amylyx Pharmaceuticals, Inc.
$179
SK Life Science, Inc.
$159
SCILEX PHARMACEUTICALS INC.
$140
ACADIA Pharmaceuticals Inc
$116
Kyowa Kirin, Inc.
$115
Celgene Corporation
$100
Novartis Pharmaceuticals Corporation
$99
Otsuka America Pharmaceutical, Inc.
$98
Lilly USA, LLC
$90
EMD Serono, Inc.
$88
CSL Behring
$85
Grifols USA, LLC
$77
MITSUBISHI TANABE PHARMA AMERICA, INC.
$73
Neuronetics, Inc.
$69
Genentech USA, Inc.
$60
UCB, Inc.
$38
MDD US Operations, LLC
$35
ARGENX US, INC.
$33
Medtronic, Inc.
$32
Acorda Therapeutics, Inc
$31
Boston Scientific Corporation
$28
Takeda Pharmaceuticals U.S.A., Inc.
$24
Octapharma USA, Inc.
$23
Alexion Pharmaceuticals, Inc.
$20
Azurity Pharmaceuticals, Inc.
$20
CATALYST PHARMACEUTICALS, INC.
$16
Vanda Pharmaceuticals Inc.
$16
Top 3 companies account for 79.3% of 2024 payments
All-time payments by company (2018-2024) ›
Eisai Inc.
$8,095
ABBVIE INC.
$1,538
PFIZER INC.
$753
SK Life Science, Inc.
$683
AbbVie Inc.
$683
Lundbeck LLC
$670
Horizon Therapeutics plc
$620
Biogen, Inc.
$501
Amgen Inc.
$427
Biohaven Pharmaceuticals, Inc.
$426
EMD Serono, Inc.
$426
Novartis Pharmaceuticals Corporation
$405
Alexion Pharmaceuticals, Inc.
$385
ACADIA Pharmaceuticals Inc
$368
Grifols USA, LLC
$363
SCILEX PHARMACEUTICALS INC.
$337
Biohaven Pharmaceutical Holding Company Ltd.
$334
Teva Pharmaceuticals USA, Inc.
$329
Sunovion Pharmaceuticals Inc.
$268
Lilly USA, LLC
$266
Celgene Corporation
$259
GENZYME CORPORATION
$255
Takeda Pharmaceuticals U.S.A., Inc.
$195
Amylyx Pharmaceuticals, Inc.
$179
UCB, Inc.
$166
US WorldMeds, LLC
$165
Neurocrine Biosciences, Inc.
$159
IMPEL PHARMACEUTICALS INC.
$144
Otsuka America Pharmaceutical, Inc.
$142
Kyowa Kirin, Inc.
$140
CSL Behring
$128
MITSUBISHI TANABE PHARMA AMERICA, INC.
$113
Supernus Pharmaceuticals, Inc.
$97
Acorda Therapeutics, Inc
$90
Genentech USA, Inc.
$86
Medtronic, Inc.
$76
MDD US Operations, LLC
$75
UPSHER-SMITH LABORATORIES LLC
$71
Neuronetics, Inc.
$69
CATALYST PHARMACEUTICALS, INC.
$66
Corium, LLC
$64
Bausch Health US, LLC
$63
ARGENX US, INC.
$61
Boehringer Ingelheim Pharmaceuticals, Inc.
$56
Octapharma USA, Inc.
$53
Vertical Pharmaceuticals, LLC
$51
Mallinckrodt Hospital Products Inc.
$49
Allergan Inc.
$48
Ipsen Biopharmaceuticals, Inc
$48
Neurelis, Inc.
$42
Promius Pharma LLC
$39
BANNER LIFE SCIENCES, LLC
$39
Almatica Pharma LLC
$37
Janssen Pharmaceuticals, Inc
$33
Amneal Pharmaceuticals LLC
$29
GE HEALTHCARE
$29
Boston Scientific Corporation
$28
ASSERTIO THERAPEUTICS, Inc.
$24
Avanir Pharmaceuticals, Inc.
$24
Xeris Pharmaceuticals, Inc.
$22
Impax Laboratories, Inc.
$21
Upsher-Smith Laboratories LLC
$21
Egalet US Inc
$20
Scilex Pharmaceuticals Inc.
$20
Azurity Pharmaceuticals, Inc.
$20
AstraZeneca Pharmaceuticals LP
$18
Alnylam Pharmaceuticals Inc.
$17
Mitsubishi Tanabe Pharma America, Inc.
$17
Mylan Specialty L.P.
$16
Vanda Pharmaceuticals Inc.
$16
Strongbridge US INC.
$15
LivaNova USA, Inc.
$15
Zyla Life Sciences, Inc.
$14
Currax Pharmaceuticals LLC
$14
GE HealthCare
$13
Medtronic USA, Inc.
$12
Allergan, Inc.
$12
Top 3 companies account for 47.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Briviact · COMIRNATY · CONTRAVE · Cambia · DUOPA · Dysport · ELYXYB - CELECOXIB · EMGALITY · FIRDAPSE · FYCOMPA · GAMMAGARD · GAMMAGARD LIQUID · GRALISE · GVOKE PFS · Gamunex-C · Glatiramer Acetate · Gocovri · Gralise · HYQVIA · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · LUX-Dx Insertable Cardiac Monitor · Leqembi · MAVENCLAD · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NEUROSTAR TMS THERAPY SYSTEM · NORTHERA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PAXLOVID · PERCEPT PC BRAINSENSE · PLEGRIDY · POMPE - DISEASE · PONVORY · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · RELEXXII · RELYVRIO · REXULTI · RYTARY · Radicava · Rystiggo · SOLIRIS · SPRIX · Soliris · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VYEPTI · VYVGART · Vimpat · XADAGO · XCOPRI · Xadago · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPOSIA · ZONISADE · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (62%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for optician in NY.
Geographic Context
Opticians within 10 mi
16,382
Per 100K population
1180.1
County median income
$143,408
Nearest hospital
LONG ISLAND JEWISH MEDICAL CENTER
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Podwall is a clinical cardiology specialist, with above-average Medicare volume (top 24% in NY), with low-engagement industry engagement in the top 8% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Podwall experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Podwall performed 583 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Podwall receive payments from pharmaceutical companies?
Yes. Dr. Podwall received a total of $21,668 from 77 companies across 758 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Podwall's costs compare to other opticians in Lake Success?
Dr. Podwall's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Podwall) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Lake Success
Browse opticians in Lake Success ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NY
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NY
Which NY opticians receive the most from drug and device companies.
By company
Eisai Inc. Payments to Doctors
See all physicians who received payments from Eisai Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology